Your browser doesn't support javascript.
loading
Efficacy of phosphodiesterase type 5 inhibitors in univentricular congenital heart disease: the SV-INHIBITION study design.
Amedro, Pascal; Gavotto, Arthur; Abassi, Hamouda; Picot, Marie-Christine; Matecki, Stefan; Malekzadeh-Milani, Sophie; Levy, Marilyne; Ladouceur, Magalie; Ovaert, Caroline; Aldebert, Philippe; Thambo, Jean-Benoit; Fraisse, Alain; Humbert, Marc; Cohen, Sarah; Baruteau, Alban-Elouen; Karsenty, Clement; Bonnet, Damien; Hascoet, Sebastien.
Afiliação
  • Amedro P; Paediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, CHU Montpellier, Montpellier, France.
  • Gavotto A; PhyMedExp, CNRS, INSERM, University of Montpellier, CHU Montpellier, Montpellier, France.
  • Abassi H; Paediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, CHU Montpellier, Montpellier, France.
  • Picot MC; Paediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, CHU Montpellier, Montpellier, France.
  • Matecki S; Department of Epidemiology and Biostatistics, CHU Montpellier, Montpellier, France.
  • Malekzadeh-Milani S; Paediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, CHU Montpellier, Montpellier, France.
  • Levy M; PhyMedExp, CNRS, INSERM, University of Montpellier, CHU Montpellier, Montpellier, France.
  • Ladouceur M; Paediatric Cardiology Department, AP-HP, Necker-Enfants malades, M3C National Reference Centre, Paris Descartes University, Sorbonne Paris Cite, Paris, France.
  • Ovaert C; Paediatric Cardiology Department, AP-HP, Necker-Enfants malades, M3C National Reference Centre, Paris Descartes University, Sorbonne Paris Cite, Paris, France.
  • Aldebert P; Adult Congenital Heart Disease Unit, Department of Cardiology, M3C National Reference Centre, European Hospital Georges Pompidou, Paris, France.
  • Thambo JB; Paediatric and Congenital Medico-Surgical Cardiology Department, M3C Regional Reference Centre, AP-HM, La Timone University Hospital, Marseille, France.
  • Fraisse A; Laboratory of Medical Genetics, INSERM UMR 1251, Aix-Marseille University, Marseille, France.
  • Humbert M; Paediatric and Congenital Medico-Surgical Cardiology Department, M3C Regional Reference Centre, AP-HM, La Timone University Hospital, Marseille, France.
  • Cohen S; Paediatric and Adult Congenital Heart Disease Department, Hôpital Cardiologique du Haut-Lévêque, M3C National Reference Centre, CHU de Bordeaux, Bordeaux, France.
  • Baruteau AE; Pediatric Cardiology Service, Royal Brompton and Harefield Hospital Trust, London, UK.
  • Karsenty C; Department of Pulmonology, PH National Reference Centre, APHP, Kremlin-Bicetre, Paris, France.
  • Bonnet D; Paris-Sud Faculty of Medicine, INSERM U999, Marie-Lannelongue Hospital, M3C National Reference Centre, Paris-Sud University, Paris-Saclay, Le Plessis-Robinson, Paris, France.
  • Hascoet S; Paris-Sud Faculty of Medicine, INSERM U999, Marie-Lannelongue Hospital, M3C National Reference Centre, Paris-Sud University, Paris-Saclay, Le Plessis-Robinson, Paris, France.
ESC Heart Fail ; 7(2): 747-756, 2020 04.
Article em En | MEDLINE | ID: mdl-32147955

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article